Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Glutamine Metabolism in HSCs and Liver Fibrosis
2026-09-11
Yin and colleagues identify SIRT4-mediated control of glutamate dehydrogenase as a metabolic brake on hepatic stellate cell activation and liver fibrosis. Their in vitro and in vivo evidence connects reduced SIRT4 expression with enhanced glutamine catabolism, HSC proliferation, and fibrotic progression, while pharmacological or genetic suppression of this pathway produced antifibrotic effects.
-
T0070907: Precision PPARγ Antagonist Workflows
2026-09-11
T0070907 is a high-affinity PPARγ antagonist for separating receptor-dependent transcription from downstream effects in adipogenesis, macrophage, and cancer models. This guide converts its covalent mechanism and nanomolar potency into practical dosing, assay-design, and troubleshooting strategies.
-
Ribociclib Succinate: Reliable Assay Design
2026-09-10
This scenario-based guide explains how Ribociclib succinate (SKU B1084) can support reproducible cell proliferation, viability, and cytotoxicity workflows. It connects CDK4/6 biology with solvent selection, pH-aware handling, endpoint interpretation, and evidence-based vendor evaluation.
-
Novel Allosteric PDK4 Inhibitors: Evidence from 8c
2026-09-10
The reference study used anthraquinone scaffold optimization to identify compound 8c, a new allosteric pyruvate dehydrogenase kinase 4 inhibitor with 84 nM biochemical potency. Its activity across glucose tolerance, allergic-response, and cancer-related models supports PDK4 as a metabolically connected target, while the preclinical design also highlights important limits in translating enzyme inhibition into therapeutic efficacy.
-
Medroxyprogesterone Acetate in Decidualization
2026-09-09
Explore how Medroxyprogesterone acetate can be used as a controlled decidualization stimulus while distinguishing progesterone signaling from ACSL4-dependent fatty acid oxidation. This evidence-led guide translates a recent endometrial metabolism study into practical assay and interpretation decisions.
-
Medroxyprogesterone Acetate: Applied Research Workflows
2026-09-09
Medroxyprogesterone acetate supports controlled studies of progestin signaling across endometrial, renal, and neurobiological models. This guide translates product specifications and a recent vitamin D/VDR decidualization study into practical assay design, optimization, and troubleshooting strategies.
-
Irinotecan Beyond Tumor Killing: The Gut–Liver Axis
2026-09-08
Irinotecan research is expanding from tumor-cell cytotoxicity toward chemotherapy-associated gut–liver injury. This article explains how CPT-11 can support integrated colorectal cancer research by connecting topoisomerase I damage, intestinal barrier failure, LPS translocation, and hepatic NET-driven inflammation.
-
RepSox and ALK5 Signaling in iPSC Platelet Research
2026-09-08
RepSox is a potent and selective ALK5 inhibitor that can help separate TGF-β pathway biology from process optimization in induced pluripotent stem cell research. This article interprets recent platelet-production findings and develops a careful assay framework for testing RepSox without confusing validated evidence with a plausible extension.
-
Medroxyprogesterone acetate: Applied Research Workflows
2026-09-07
Medroxyprogesterone acetate (MPA) provides a defined steroidal perturbation for endometrial, renal, and neurobiological models. This guide converts its solubility, dose-range, and receptor-context data into practical workflows, while using a recent decidualization study to sharpen assay selection and troubleshooting.
-
PD-0332991 Plus Cisplatin in NSCLC Resistance
2026-09-07
The reference study investigates whether PD 0332991, a CDK4/6 inhibitor, can enhance cisplatin activity and reverse acquired cisplatin resistance in NSCLC cell models. Its central finding is that combined treatment suppresses proliferation, increases apoptosis and G0/G1 arrest, and modulates the Rb–E2F pathway, providing a mechanistic basis for further preclinical study.
-
RNA G-Quadruplexes Modulate TDP-43 Toxicity
2026-09-05
Oldani et al. show that RNA G-quadruplexes directly influence TDP-43 aggregation, condensation, intracellular distribution, and toxicity across biochemical and cellular models. The study supports a structure-centered strategy for investigating protein-misfolding diseases while also defining important boundaries between RNA G-quadruplex biology and DNA-targeting ligands.
-
Taltirelin acetate: Preclinical Workflow Guide
2026-09-04
Taltirelin acetate connects TRHR1 signaling with practical neuroprotection, behavioral, sleep-related, itch, and formulation assays. This guide translates the MPTP and rotenone findings into executable workflows, assay controls, and troubleshooting strategies for translational researchers.
-
Gap26 and the Translational Logic of Cx43 Blockade
2026-09-04
Gap26 offers a practical way to interrogate connexin 43-dependent ATP, calcium, and inflammatory signaling. This thought-leadership guide connects mechanism, validation strategy, and translational decision-making across vascular and neurobiology research.
-
Ridaforolimus and the Next mTOR Research Frontier
2026-09-03
Ridaforolimus, also known as Deforolimus or MK-8669, provides a highly potent framework for interrogating mTOR-dependent growth, translation, metabolism, and angiogenic signaling. Combined with machine-learning approaches to senolytic discovery, it supports a more disciplined translational strategy: separate pathway engagement from cell-state selectivity, validate both with orthogonal assays, and advance only the most reproducible biological hypotheses.
-
Halazone: From Chloramine Chemistry to Assay Design
2026-09-03
Halazone is an antimicrobial sulfonamide derivative with a practical dual identity: a water disinfection agent and an oxidant that alters neuronal sodium-current inactivation. This assay-focused guide explains how concentration, redox conditions, formulation stability, and voltage-clamp design determine interpretable results.